Ganglioside GM1 and the Central Nervous System

被引:23
作者
Guo, Zhongwu [1 ]
机构
[1] Univ Florida, Dept Chem, Gainesville, FL 32611 USA
关键词
central nervous system; glycan; glycolipid; glycosphingolipid; function; neurological disease; AMYLOID BETA-PROTEIN; CHEMICAL CHAPERONE THERAPY; CEREBELLAR GRANULE CELLS; TOXIN-B-SUBUNIT; CHAIN BASE COMPOSITION; AMYOTROPHIC-LATERAL-SCLEROSIS; TREATMENT PROMOTES RECOVERY; REDUCES NMDA NEUROTOXICITY; MODULATES NUCLEAR CALCIUM; GD3 SYNTHASE PROTECTS;
D O I
10.3390/ijms24119558
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
GM1 is one of the major glycosphingolipids (GSLs) on the cell surface in the central nervous system (CNS). Its expression level, distribution pattern, and lipid composition are dependent upon cell and tissue type, developmental stage, and disease state, which suggests a potentially broad spectrum of functions of GM1 in various neurological and neuropathological processes. The major focus of this review is the roles that GM1 plays in the development and activities of brains, such as cell differentiation, neuritogenesis, neuroregeneration, signal transducing, memory, and cognition, as well as the molecular basis and mechanisms for these functions. Overall, GM1 is protective for the CNS. Additionally, this review has also examined the relationships between GM1 and neurological disorders, such as Alzheimer's disease, Parkinson's disease, GM1 gangliosidosis, Huntington's disease, epilepsy and seizure, amyotrophic lateral sclerosis, depression, alcohol dependence, etc., and the functional roles and therapeutic applications of GM1 in these disorders. Finally, current obstacles that hinder more in-depth investigations and understanding of GM1 and the future directions in this field are discussed.
引用
收藏
页数:32
相关论文
共 418 条
  • [1] PREDICTIVE VALUE OF ANTI-GM1 GANGLIOSIDE ANTIBODIES IN NEUROMUSCULAR DISEASES - A STUDY OF 180 SERA
    ADAMS, D
    KUNTZER, T
    BURGER, D
    CHOFFLON, M
    MAGISTRIS, MR
    REGLI, F
    STECK, AJ
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1991, 32 (03) : 223 - 230
  • [2] Agnati L F, 1984, Acta Physiol Scand Suppl, V532, P37
  • [3] Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration
    Akkhawattanangkul, Y.
    Maiti, P.
    Xue, Y.
    Aryal, D.
    Wetsel, W. C.
    Hamilton, D.
    Fowler, S. C.
    McDonald, M. P.
    [J]. GENES BRAIN AND BEHAVIOR, 2017, 16 (05) : 522 - 536
  • [4] Disease-modifying effects of ganglioside GM1 in Huntington's disease models
    Alpaugh, Melanie
    Galleguillos, Danny
    Forero, Juan
    Morales, Luis Carlos
    Lackey, Sebastian W.
    Kar, Preeti
    Di Pardo, Alba
    Holt, Andrew
    Kerr, Bradley J.
    Todd, Kathryn G.
    Baker, Glen B.
    Fouad, Karim
    Sipione, Simonetta
    [J]. EMBO MOLECULAR MEDICINE, 2017, 9 (11) : 1537 - 1557
  • [5] GM1 Ganglioside Inhibits β-Amyloid Oligomerization Induced by Sphingomyelin
    Amaro, Mariana
    Sachl, Radek
    Aydogan, Gokcan
    Mikhalyov, Ilya I.
    Vacha, Robert
    Hof, Martin
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (32) : 9411 - 9415
  • [6] Gangliosides and sialylcholesterol as modulators of synaptic functions
    Ando, S
    Tanaka, Y
    Waki, H
    Kon, K
    Iwamoto, M
    Fukui, F
    [J]. SPHINGOLIPIDS AS SIGNALING MODULATORS IN THE NERVOUS SYSTEM, 1998, 845 : 232 - 239
  • [7] ANDO S, 1977, J BIOL CHEM, V252, P6247
  • [8] Regulation of ceramide-induced neuronal death: Cell metabolism meets neurodegeneration
    Arboleda, Gonzalo
    Morales, Luis Carlos
    Benitez, Bruno
    Arboleda, Humberto
    [J]. BRAIN RESEARCH REVIEWS, 2009, 59 (02) : 333 - 346
  • [9] Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease - a review
    Ariga, Toshio
    McDonald, Michael P.
    Yu, Robert K.
    [J]. JOURNAL OF LIPID RESEARCH, 2008, 49 (06) : 1157 - 1175
  • [10] GM1 Ganglioside: Past Studies and Future Potential
    Aureli, Massimo
    Mauri, Laura
    Ciampa, Maria Grazia
    Prinetti, Alessandro
    Toffano, Gino
    Secchieri, Cynthia
    Sonnino, Sandro
    [J]. MOLECULAR NEUROBIOLOGY, 2016, 53 (03) : 1824 - 1842